LINC01582

Across TCGA pan-cancer cohorts, LINC01582 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC01582’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where LINC01582 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01582 is over-expressed in tumor.

LUSC, LUAD, and HNSC are the cancer types where LINC01582 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01582 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	+0.117	.002	2	view →
LUAD	All	III,IV	+0.039	.032	2	view →
HNSC	All	IV	+0.039	.023	2	view →
KIRP	All	All	+0.032	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

LINC01582–LUSC

Open the LUSC breakdown →